Literature DB >> 18751947

Further study of anti-ICOS immunotherapy for rat cardiac allograft rejection.

Xuan-Chao Pan1, Lei Guo, Ying-Bing Deng, Katsutoshi Naruse, Hiromitsu Kimura, Yasuhiko Sugawara, Masatoshi Makuuchi.   

Abstract

PURPOSE: To study the effect of B7-CD28 costimulatory signal blockade by adenovirus-mediated cytotoxic T-lymphocyte-associated antigen 4 immunoglobulin (AdCTLA-4Ig) on cardiac allograft survival in DA (RT1(a)) to LEW (Lewis RT1(l)) rat combinations.
METHODS: We evaluated the effect of combined AdCTLA-4Ig and anti-inducible costimulator (ICOS) antibody immunotherapy on rat cardiac allograft acceptance.
RESULTS: Unlike AdCTLA-4Ig alone, anti-ICOS immunotherapy combined with AdCTLA-4Ig induced stable tolerance without causing chronic rejection. The combined immunotherapy also prevented the accelerated cardiac rejection caused by donor-type test skin grafting. Immunohistochemical analyses revealed remarkable inflammatory mononuclear cell infiltration with typical vasculopathy, especially ICOS-positive cells in the grafts, in recipients treated with AdCTLA-4Ig alone. In contrast, anti-ICOS therapy combined with AdCTLA-4Ig reduced the ICOS-positive inflammatory cell infiltration of the graft significantly. The most important finding is that possible cardiac arrest caused by secondary donor-type skin graft was prevented by combined immunotherapy of AdCTLA-4Ig and anti-ICOS antibody, despite skin graft rejection.
CONCLUSIONS: Our results identified a major role played by the ICOS-ICOSL pathway in chronic and accelerated cardiac allograft rejection, providing a novel approach to preventing the chronic rejection of vascularized organ allografts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18751947     DOI: 10.1007/s00595-007-3734-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  44 in total

1.  Functional responses and costimulator dependence of memory CD4+ T cells.

Authors:  C A London; M P Lodge; A K Abbas
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

2.  Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.

Authors:  Cécile Guillot; Carole Guillonneau; Patrick Mathieu; Christian A Gerdes; Séverine Ménoret; Cécile Braudeau; Laurent Tesson; Karine Renaudin; Maria G Castro; Pedro R Löwenstein; Ignacio Anegon
Journal:  J Immunol       Date:  2002-02-15       Impact factor: 5.422

3.  ICOS co-stimulatory receptor is essential for T-cell activation and function.

Authors:  C Dong; A E Juedes; U A Temann; S Shresta; J P Allison; N H Ruddle; R A Flavell
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

4.  A new analysis of allogeneic interactions.

Authors:  K J Lafferty; A J Cunningham
Journal:  Aust J Exp Biol Med Sci       Date:  1975-02

5.  The roles of CD28 and CD40 ligand in T cell activation and tolerance.

Authors:  K C Howland; L J Ausubel; C A London; A K Abbas
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

6.  Heavy metal intensification of DAB-based HRP reaction product.

Authors:  J C Adams
Journal:  J Histochem Cytochem       Date:  1981-06       Impact factor: 2.479

7.  In vitro analysis of CD40-CD154 and CD28-CD80/86 interactions in the primary T-cell response to allogeneic "nonprofessional" antigen presenting cells.

Authors:  J C Laning; J E Deluca; C M Isaacs And; J Hardin-Young
Journal:  Transplantation       Date:  2001-05-27       Impact factor: 4.939

8.  Inducible costimulator regulates Th2-mediated inflammation, but not Th2 differentiation, in a model of allergic airway disease.

Authors:  A G Tesciuba; S Subudhi; R P Rother; S J Faas; A M Frantz; D Elliot; J Weinstock; L A Matis; J A Bluestone; A I Sperling
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

9.  ICOS contributes to T cell expansion in CTLA-4 deficient mice.

Authors:  Miranda E A T van Berkel; Elise H R Schrijver; Frans M A Hofhuis; Arlene H Sharpe; Anthony J Coyle; Chris P Broeren; Kiki Tesselaar; Mariëtte A Oosterwegel
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

10.  AILIM/ICOS: its expression and functional analysis with monoclonal antibodies.

Authors:  S Sakamoto; K Tezuka; T Tsuji; N Hori; T Tamatani
Journal:  Hybrid Hybridomics       Date:  2001
View more
  9 in total

1.  Current status of and prospects for the English medical journal Surgery Today.

Authors:  Yoshihiko Maehara; Yoshihiro Kakeji
Journal:  Surg Today       Date:  2010-12       Impact factor: 2.549

2.  Costimulation blockade inhibits the indirect pathway of allorecognition in nerve allograft rejection.

Authors:  Wilson Z Ray; Rahul Kasukurthi; Santosh S Kale; Katherine B Santosa; Daniel A Hunter; Philip Johnson; Ying Yan; Thalachallour Mohanakumar; Susan E Mackinnon; Thomas H Tung
Journal:  Muscle Nerve       Date:  2011-01       Impact factor: 3.217

3.  Regulation of T cell response by blocking the ICOS signal with the B7RP-1-specific small antibody fragment isolated from human antibody phage library.

Authors:  Masatoshi Maeda; Yuji Ito; Takaaki Hatanaka; Shuhei Hashiguchi; Masaharu Torikai; Toshihiro Nakashima; Kazuhisa Sugimura
Journal:  MAbs       Date:  2009-09-26       Impact factor: 5.857

4.  Inducible costimulatory molecule deficiency induced imbalance of Treg and Th17/Th2 delays rejection reaction in mice undergoing allogeneic tracheal transplantation.

Authors:  Jingsong Xu; Yu Wu; Guifang Wang; Yanghua Qin; Li Zhu; Gusheng Tang; Qian Shen
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

Review 5.  Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeutics.

Authors:  Chuda Chittasupho; Teruna J Siahaan; Charlotte M Vines; Cory Berkland
Journal:  Ther Deliv       Date:  2011-07

6.  Inducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic target.

Authors:  Masahiko Sato; Rainer Storb; Carol Loretz; Diane Stone; Marco Mielcarek; George E Sale; Andrew R Rezvani; Scott S Graves
Journal:  Transplantation       Date:  2013-07-15       Impact factor: 4.939

7.  CD28 family and chronic rejection: "to belatacept...And beyond!".

Authors:  Marcos V Silva; Juliana R Machado; Laura P Rocha; Lúcio R Castellano; Marlene A Reis; Rosana R M Corrêa
Journal:  J Transplant       Date:  2012-06-07

Review 8.  ICOS Co-Stimulation: Friend or Foe?

Authors:  Daniel J Wikenheiser; Jason S Stumhofer
Journal:  Front Immunol       Date:  2016-08-10       Impact factor: 7.561

9.  Pilot Study of Delayed ICOS/ICOS-L Blockade With αCD40 to Modulate Pathogenic Alloimmunity in a Primate Cardiac Allograft Model.

Authors:  Natalie A O'Neill; Tianshu Zhang; Gheorghe Braileanu; Xiangfei Cheng; Alena Hershfeld; Wenji Sun; Keith A Reimann; Sia Dahi; Natalia Kubicki; Wessam Hassanein; Christopher Laird; Arielle Cimeno; Agnes M Azimzadeh; Richard N Pierson
Journal:  Transplant Direct       Date:  2018-02-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.